JPRN-UMIN000002220已完成未知
se of accelerator Mass Spectrometry to measure the pharmacokinetics and metablites analysis of C14-labled tolbutamide - Use of accelerator Mass Spectrometry to measure the pharmacokinetics and metablites analysis of C14-labled tolbutamide
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- APDD
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 45years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •the investigators must ensure that all subjects being considered meet the following exclusion criteria or conditions 1)diabetes or blood glucose abnormality 2)dysemia 3)history of cardiac disease 4)impairmant of liver or kidney functions 5)any medical condition that reqires medical attention 6)recent (past 4 months) participation in other clinical trial and the investigator determines this trial participation inadequate 7)history of allergy to tolbutamide 8)donation of 400mL or more of blood within 3 months prior to participation, donation of 200mL or more of blood within 1 month prior to participation, or donation of component blood within 2 weeks prior to participation 9)positive serologic reaction of syphilis, positive results of HIV test, HBsAg and HCVAb 10)history of multiple and recurning allergies to medicines or food 11)history of drug or alcohol abuse 12)the investigator determines this trial participation inadequate
研究者
相似试验
已完成
不适用
Establishment of mass spectrometric determination of drugs in hair and its application to forensic medicine and pharmacokinetic analysisDrug abuseJPRN-UMIN000013312Osaka Medical College5
招募中
不适用
Multidimensional mass-spectrometry for early detection of severe sepsis/septic shock in patients with neutropenic fever – a pilot study.A41.9Sepsis, unspecifiedDRKS00000647Institut für Klinische Chemie und LaboratoriumsdiagnostikCenter for Sepsis Control and Care (CSCC)Klinikum Lobeda120
尚未招募
不适用
Validation of 3.0 Tesla 1H-MR Spectroscopy for assessment of liver steatosis in patients with non-alcoholic fatty liver disease and chronically infected hepatitis Cfatty liverhepatitis Cjaundiceliversteatosis10019654NL-OMON31271Academisch Medisch Centrum60
已完成
不适用
Construction of compound detection system by mass spectrometry for biological samples obtained at Critical Care Center and examination of its operabilityDrug intoxicationJPRN-UMIN000035447Teikyo University500
已完成
不适用
ovel mass spectrometric monitoring (steroid metabolomics) to detect treatment success and chronic over- or under-treatment in children with CAH (CAH metabolomics).NL-OMON44301Erasmus MC, Universitair Medisch Centrum Rotterdam50